Through the utilization of IL-33−/− mice, we demonstrate that the loss of host-derived IL-33 promotes tumor growth and induces alterations in the infiltration patterns of ILC2s, CD4+ T cells, and CD8+ T cells. Here, IL33 is linked to neoplasm.